No "Statistical Alchemy" Here: Meta-Analyses Can Reduce Trial Size

Hints about the direction FDA's Meta-Analysis Working Group may take in drafting guidance, and the Institute of Medicine may adopt in twin reports on the subject, can be found in journal articles by Joseph Lau, a professor of medicine at Tufts who is involved in all three efforts (see 1preceding story)